Are Statins an Option in the Management of Abdominal Aortic Aneurysms?
Author(s) -
Kosmas I. Paraskevas,
Christos D. Liapis,
George Hamilton,
Dimitri P. Mikhailidis
Publication year - 2008
Publication title -
vascular and endovascular surgery/vascular and endovascular surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.46
H-Index - 45
eISSN - 1938-9116
pISSN - 1538-5744
DOI - 10.1177/1538574407308205
Subject(s) - medicine , perioperative , abdominal aortic aneurysm , aneurysm , statin , cardiology , population , aortic aneurysm , clinical trial , radiology , surgery , intensive care medicine , environmental health
Medline was searched for studies investigating the perioperative and long-term results that derive from statin use in patients with abdominal aortic aneurysm and the clinical and experimental evidence dealing with aneurysm expansion. Data suggest that statins improve the perioperative and long-term outcomes of aneurysm operations and may also reduce expansion rates. International guidelines recommend the use of statins in these patients because abdominal aortic aneurysms are considered as a coronary heart disease equivalent. These guidelines do not appear to have been widely implemented. Preliminary results suggest that statins might play a role in the management of abdominal aortic aneurysms. Verification of these results in large-scale trials may hold implications for a more comprehensive approach of patients with abdominal aortic aneurysms as well as population-wide aneurysm screening programs. Irrespective of the role of statins on aneurysm expansion rates, it is important to ensure that all abdominal aortic aneurysm patients receive statin therapy to improve perioperative and long-term morbidity and mortality.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom